Semax vs Selank
Two nootropic peptides with opposite cognitive profiles — Semax boosts focus through BDNF while Selank reduces anxiety via GABA modulation.
Comparison Overview
Semax and Selank are frequently compared as they were both developed at the same institution, the Institute of Molecular Genetics of the Russian Academy of Sciences, and both are approved prescription medications in Russia for neurological applications. Despite their shared origin, they represent complementary approaches to cognitive optimization: Semax provides stimulating nootropic effects through BDNF upregulation, while Selank provides anxiolytic nootropic effects through GABAergic modulation.
The distinction is not merely between 'stimulating' and 'calming', it reflects fundamentally different neuropharmacological strategies. Semax enhances cognitive capacity by upregulating the molecular infrastructure for synaptic plasticity (BDNF) and modulating motivational neurotransmission (dopamine). Selank enhances cognitive expression by removing the anxiety-mediated interference that prevents existing cognitive capacity from being utilized, the phenomenon neuroscience calls 'prefrontal hijacking' by the amygdala.
This comparison helps individuals and their specialists determine which peptide better matches their cognitive-emotional profile, or whether a combination approach offers the most comprehensive cognitive optimization.
Side-by-Side Specifications
| Specification | Semax | Selank |
|---|---|---|
| Format | Nasal Spray Preparation | Nasal Spray Preparation |
| Amount | 30mg total | 15mg total |
| Purity | >99.8% | >99.6% |
| Molecular Weight | 813.93 g/mol | 751.90 g/mol |
Head-to-Head Scorecard
Pure Cognitive Enhancement
Semax is the superior pure cognitive enhancer, rapidly upregulating BDNF in the hippocampus and cortex for enhanced synaptic plasticity, memory formation, and processing speed. Its dopaminergic modulation directly supports executive function and sustained attention. Selank preserves cognitive function rather than actively enhancing it.
Anxiety Reduction
Selank is the dedicated anxiolytic, with clinical approval in Russia for generalized anxiety disorder. Its GABAergic gene expression modulation produces anxiolysis comparable to benzodiazepines without sedation or dependence. Semax has mild mood-stabilizing properties through enkephalinase inhibition but is not a primary anxiolytic.
Safety Profile
Both have excellent safety profiles documented through decades of prescription use in Russia. Selank edges slightly ahead due to fewer theoretical concerns, its GABAergic gene modulation is gentler than Semax's dopaminergic effects, and it carries no stimulant-like considerations. Neither produces tolerance, dependence, or significant adverse effects.
Clinical Evidence
Both compounds have extensive clinical evidence, each approved as a prescription medication in Russia with decades of use. Semax has been approved since 2001 (cognitive enhancement, neuroprotection, stroke) and Selank since 2009 (generalized anxiety disorder). Both have peer-reviewed publications supporting their mechanisms and clinical applications.
Versatility
Semax's broader transcriptomic effects (1,000+ genes in the brain) and neuroprotective properties give it wider potential applications, cognitive enhancement, neuroprotection, stroke recovery, and mood support. Selank is more focused on anxiolysis and immunomodulation. Both are versatile within their domains.
When to Choose Each
Pure focus and productivity enhancement
For individuals seeking sharper focus, faster information processing, and enhanced mental clarity without anxiety concerns, Semax is the clear choice. Its BDNF upregulation enhances the brain's synaptic plasticity, the molecular basis of learning and sustained attention, while dopaminergic modulation provides the motivational drive for sustained cognitive work. Effects are typically noticed within 2-3 days. A specialist would determine the appropriate dose based on neurological profile.
Anxiety-impaired cognitive performance
When anxiety, worry, or stress directly interfere with cognitive function, the experience of racing thoughts preventing concentration, or performance anxiety undermining mental clarity, Selank addresses the root cause by reducing anxious arousal through GABAergic modulation while preserving and enhancing cognitive function. This is the rare anxiolytic that improves rather than impairs thinking. A specialist would evaluate anxiety profile to confirm this approach.
High-pressure performance environments
Demanding environments requiring both peak cognitive performance and emotional composure (presentations, examinations, high-stakes decision-making) may benefit from the combination, Semax providing cognitive enhancement while Selank prevents anxiety from undermining performance. This combination requires careful specialist-guided dosing of both compounds to achieve the optimal balance of stimulating and calming effects. A specialist would titrate doses based on individual response.
Age-related cognitive decline concerns
Semax's BDNF upregulation directly addresses the decline in neurotrophic factor expression that contributes to age-related cognitive deterioration. BDNF levels naturally decrease with age, reducing synaptic plasticity and neurogenesis. Semax's ability to restore BDNF expression in the hippocampus, the brain's memory center, makes it the primary choice for age-related cognitive support. Clinical research has shown improved cognitive outcomes in elderly populations. A specialist would assess for other causes of cognitive decline.
Mechanism Breakdown
Semax and Selank operate through entirely distinct neuropharmacological mechanisms, despite both being heptapeptides administered intranasally. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an ACTH(4-10) analogue that primarily drives neurotrophic factor upregulation. Within hours of administration, Semax significantly increases BDNF and NGF mRNA expression in the hippocampus and cortex, enhancing the molecular foundation for synaptic plasticity, learning, and memory. It simultaneously modulates dopamine and DOPAC levels in prefrontal and limbic regions, supporting executive function and motivation. Additionally, Semax inhibits enkephalinases that degrade endogenous opioid peptides, contributing mild mood-stabilizing effects. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a tuftsin analogue that primarily modulates inhibitory neurotransmission. It influences GABA-A receptor subunit gene expression, specifically alpha-2 and alpha-6 subunits, associated with anxiolysis without sedation. Unlike benzodiazepines, which enhance GABA function through allosteric receptor modulation (causing tolerance and dependence), Selank's gene-level changes create a physiologically normalized GABAergic tone. Selank additionally modulates serotonin metabolism in the hypothalamus and frontal cortex, and inherits immunomodulatory properties from its parent compound tuftsin. The key functional distinction: Semax enhances cognitive capacity (making the brain more capable), while Selank removes cognitive interference (allowing existing capacity to be fully expressed). These are complementary rather than competing effects.
View Full Compound Details
Semax
Neurogenic Peptide, BDNF Upregulation for Cognitive Enhancement
- Cognitive Enhancement
- Neuroprotection
- Memory & Learning Support
- Mood Stabilization
Selank
Anxiolytic Nootropic, GABAergic Modulation for Calm Focus
- Anxiolysis Without Sedation
- Preserved Cognitive Function
- Immune System Modulation
- No Dependence or Tolerance
Frequently Asked Questions
Combination protocols are sometimes investigated for balanced cognitive-emotional enhancement. Semax provides stimulating nootropic effects while Selank provides calming anxiolytic effects, creating a balance of enhanced focus with emotional composure. However, combining compounds that affect multiple neurotransmitter systems requires careful specialist supervision for appropriate dosing and monitoring.
Both compounds have excellent safety profiles documented through decades of prescription use in Russia. Neither produces tolerance, dependence, or significant adverse effects. Selank has a marginally more conservative profile due to its GABAergic mechanism being less activating than Semax's dopaminergic effects. Long-term use of either should be guided by a qualified specialist with appropriate cycling.
Both Semax and Selank are research-quality compounds requiring qualified medical supervision. They modulate neurotransmitter systems that interact with psychiatric medications, SSRIs, benzodiazepines, MAOIs, antipsychotics, and stimulants all affect the same pathways. Professional assessment ensures safe, effective protocols tailored to neurological profile.
Semax effects are typically noticed within 2-3 days of intranasal administration, as BDNF upregulation occurs rapidly. Selank's anxiolytic effects are usually noted within the first week. Both reach peak efficacy during the middle of their respective cycle periods. Effects on synaptic plasticity and gene expression continue to develop throughout the cycle.
Neither is a stimulant in the traditional sense. Semax enhances cognition through neurotrophic factor upregulation and neurotransmitter modulation, not through direct receptor stimulation that produces stimulant effects. It does not cause jitteriness, appetite suppression, sleep disruption, or energy crashes. Selank is explicitly non-stimulating, providing calm rather than arousal.
Need help deciding between Semax and Selank?
A specialist can evaluate which compound is most appropriate for your individual situation.
Speak with a Specialist Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026